Urica Therapeutics

About:

Urica Therapeutics is a clinical-stage biopharmaceutical company developing pharmaceutical products to treat gout and kidney diseases.

Website: https://uricatherapeutics.com/

Description:

Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases. Urica is a subsidiary company of Fortress Biotech.

Total Funding Amount:

$2.53M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Miami, Florida, United States

Founded Date:

2021-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-01-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai